International Clinical Trials |
 |
|
|
|
|
 |
| |
|
|
|
|
Clinical Trial Supply Chains Accelerated by Labelling Innovation
Steve Ellison at PRISYM ID
PRISYM ID explains how to speed up your clinical trial labelling processes as part of a cohesive supply chain
|
|
|
|
The Real-World Scenario
ICT discusses with UBC the impact of real-world data on the pharmaceutical industry, and where the future of this evidence will lead
|
|
|
|
|
|
Wellbeing in Drug Delivery Marketing
Paul Williamson at Realia Marketing
When your day job is focused on improving health outcomes for others, there isn’t always the time to look after yourself. A panel of experts discussed why looking after yourself is integral to looking after your strategy in the drug delivery marketing field
|
|
|
|
Pandemic Reflections on Whistleblowing Law in the UK
Paula Chan at BDBF
What can employees or workers do in order to gain the protection of whistleblowing law, and what should they do if they are victimised?
|
|
|
|
Future Factories – Optimising Operations
Perry Zalevsky at AVEVA
The next generation of pharma factories is as much a digital entity as it is a mechanical one
|
|
|
|
Achieving Flexibility in Clinical Contract Manufacturing
Katie Farley at MasterControl
The pharma industry relies on quick, effective decision-making from its leaders. To improve efficiency, businesses should utilise contemporary digital solutions in manufacturing
|
|
|
|
|
|
Top 10 Factors to Design and Deploy a Decentralised Clinical Trial
Dr Isaac R Rodriguez-Chavez at ICON
The design of a clinical trial can have a definitive impact on the success of approval, but there isn’t just an advantage to be gained through regulatory angles, trial design can have a big impact on the patient
|
|
|
|
How Contingency Plans Became the New Normal
Anthony Poynton at Premier Research
Understanding how to run clinical trials remotely, and still deliver valid results, has progressed from an interim step to the way we do business. Employing suitable strategies to mitigate and manage risk means first learning how to leverage mHealth
|
|
|
|
Adapt and Update: The Benefits of Bayesian
Dr Yannis Jemiai, Chief Scientific Officer at Cytel, discusses the impact of Bayesian and adaptive clinical trial designs amid COVID-19, and glances to their expanded future adoption post-pandemic
|
|
|
|
Smart Home Devices Foster the Next Generation of Decentralised Clinical Trials
Tom Rhoads at Spencer Health Solutions
To better engage with patients, clinical trial providers are using technology and digital solutions to bring healthcare into participants’ homes
|
|
|
|
Clinical Trial Design and Build
Steven Benham at Formedix
Advanced, all-in-one, cloud-based clinical metadata repositories are helping to standardise clinical study design and build, increase throughput, and decrease costs
|
|
|
|
Anti-Infective Development Requires a New Approach to Clinical Trial Design
Jonathan Andrus at Clinical Ink
Lessons learned from deploying decentralised trials during COVID-19 are expected to carry through into future practices of the industry
|
|
|
|
|
|
Immediate Impact
Liz Brennan at Wellington Eye Clinic
As a result of the COVID-19 pandemic, 70% of all clinical trials are behind schedule. There is a fervent demand for CROs and site-level changes to help streamline clinical trials
|
|
|
|
How AI Is Helping Speed Drugs to Market Through Simulating Trials
Luca Emili at InSilicoTrials Technologies SpA
Product approvals can depend on numerous elements of a trial coming together, but by simulating trials in silico, the pharmaceutical industry can save time and costs
|
|
|
|
Evolution and Revolution in Site Management
Emil Hoeck at Signant Health
While virtual and decentralised trials continue to proliferate and evolve, challenges still remain for sitebased trials. A novel approach to clinical site monitoring could redefine the future of medical research
|
|
|
|
The Power of AI to Change the Rare Disease Paradigm
Allison Tyler and Wout Brusselaers at Deep 6 AI
Using AI, precision matching research criteria to patient characteristics can solve recruitment shortages in minutes rather than in months
|
|
|
|
|
|
The Barometer of Engagement
Bernard Vrijens at AARDEX Group
Building sustainable patient-centric trials to weather the storm of COVID-19 involves the utilisation of smart connected devices and packaging to reduce the burden on patients
|
|
|
|
Patient Engagement in the New Age of Clinical Trials
Barbara Lopez Kunz and Courtney Granville at DIA
Patient engagement has become common practice within clinical trials. However, work must continue to define the most high-value elements across the therapeutic development ecosystem – those that drive the greatest efficiency in bringing safe and effective approaches to patients
|
|
|
|
|
|
